Organotypic cultures of locust embryo central nervous system (CNS) were used to study the influence of hormonal factors on neurite outgrowth. Explants from the third thoracic ganglion (embryonic day 9) were grown in a serum-free medium and exposed to insulin, neuroparsin, a recently characterized insect neurohormone, somatostatin and two insect hormones: 20-hydroxyecdysone and juvenile hormone. These hormonal factors were tested either alone or in several combinations. In our culture system both insulin and neuroparsin promoted extensive neurite outgrowth. Their effects were quantitatively similar. Somatostatin had no effect on neurite formation, but was a growth factor for glial cells. 20-hydroxyecdysone was a required factor for glial cell and neurite survival. Juvenile hormone did not have any observable effects in this culture system. When insulin was added in combination with 20-hydroxyecdysone the stimulation of neurite outgrowth exceeded that seen when insulin was added alone. A similar enhancement was observed with the combination of neuroparsin and 20-hydroxyecdysone. We conclude that in locusts: (i) insulin can be implicated as a neurotrophic factor as in vertebrates; and (ii) neuroparsin, a locust neurohormone, can also be characterized as a neurotrophic factor for the locust. Moreover, both neurohormones interact synergistically with the steroid hormone 20-hydroxyecdysone to enhance neurite growth.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1460-9568.1990.tb00468.x | DOI Listing |
Biomacromolecules
January 2025
School of Life Science and Health Engineering, Jiangnan University, Wuxi 214122, China.
Three chondroitin sulfate (CS) analogues with predominant subtypes (A, C, and E) were prepared from engineered K4 combined with regioselective sulfation. CS with the designed sulfates as the main components was characterized by nuclear magnetic resonance spectroscopy, elementary analysis, and disaccharide analysis. CS prepared from the native or degraded capsular polysaccharide had molecular weights of 1.
View Article and Find Full Text PDFAnn Med
December 2025
Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Background: Pleiotrophin (PTN), a secreted multifunctional growth factor, is highly expressed in the developing brain. Recently, many studies have indicated that PTN participates in the development of brain and plays a neuroprotection after brain injury, especially promoting neuronal survival and neurite outgrowth, stimulating oligodendrocyte maturation and myelination, modulating neuroinflammation, and so on.
Objective: However, no reviews comprehensively summarize the roles of PTN in brain injuries.
Genes Cells
January 2025
Department of Genetic Biochemistry, The National Institutes of Biomedical Innovation, Health and Nutrition, Shinjuku-ku, Tokyo, Japan.
Catalytic subunit of DNA polymerase ζ (REV3), involved in translesion-replication is evolutionarily conserved from yeast and plants to higher eukaryotes. However, a large intermediate domain is inserted in REV3 of humans and mice. The domain has "DUF4683" region, which is significantly similar to human neurite extension and migration factor (NEXMIF).
View Article and Find Full Text PDFSci Rep
January 2025
Centro de Investigación en Medicina Traslacional "Severo R. Amuchástegui" (CIMETSA), Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Av. Naciones Unidas 420, Barrio Parque Vélez Sarsfield, X5016KEJ, Córdoba, Argentina.
Extracellular vesicles (EVs) play a critical role in the development of neural cells in the central nervous system (CNS). Human neural rosettes (hNRs) are radial cell structures that assemble from induced pluripotent stem cells (hiPSCs) and recapitulate some stages of neural tube morphogenesis. Here we show that hiPSCs and hNRs secrete EVs (hiPSC-EVs and hNR-EVs) with distinctive protein cargoes.
View Article and Find Full Text PDFBiomed Pharmacother
January 2025
College of Veterinary Medicine, Konkuk University, 120, Neungdong-ro, Gwangjin-gu, Seoul 05029, Republic of Korea. Electronic address:
Rett syndrome (RTT) is a neurological disorder caused by a mutation in the X-linked methyl-CpG binding protein 2 (MECP2), leading to cognitive and motor skill regression. Therapeutic strategies aimed at increasing brain-derived neurotrophic factor (BDNF) levels have been reported; however, BDNF treatment has limitations, including the inability to penetrate the blood-brain barrier, a short half-life, and potential for adverse effects when administered via intrathecal injection, necessitating novel therapeutic approaches. In this study, we focused on the adenosine A receptor (AR), which modulates BDNF and its downstream pathways, and investigated the therapeutic potential of CGS21680, an AR agonist, through in vitro and in vivo studies using R106W RTT model.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!